32.48BMarket Cap
12.79P/E TTM
Key Figures
75.610Open
77.520High
5.02MVolume
12.79P/E TTM
10.73P/E Dynamic
2.060Dividend TTM
1.19%Turnover Ratio
76.030Prev. Close
74.910Low
182.50MTurnover
13.07P/E Static
10.05P/B
2.67%Div Yield TTM
18.07%ROA
172.23052wk High
1.00Volume Ratio
2.49BNet Profit
420.35MShares
6.0419EPS TTM
0.77Beta
67.01%ROE
72.38052wk Low
3.43%Amplitude
70.29%Gross Margin
32.48BMarket Cap
1.02Reward/Risk
1.61%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Zoetis Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 20 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 105.95.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Zoetis Inc Highlights
StrengthsRisks
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Zoetis Inc Info
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Ticker SymbolZTS
CompanyZoetis Inc
CEOPeck (Kristin C)
Websitehttps://www.zoetis.com/
Shareholders
FAQs
What is the current price of Zoetis Inc (ZTS)?
The current price of Zoetis Inc (ZTS) is 77.28.
What is the symbol of Zoetis Inc?
The ticker symbol of Zoetis Inc is ZTS.
What is the 52-week high of Zoetis Inc?
The 52-week high of Zoetis Inc is 172.23.
What is the 52-week low of Zoetis Inc?
The 52-week low of Zoetis Inc is 72.38.
What is the market capitalization of Zoetis Inc?
The market capitalization of Zoetis Inc is 32.48B.
Is Zoetis Inc (ZTS) currently rated as Buy, Hold, or Sell?
According to analysts, Zoetis Inc (ZTS) has an overall rating of Buy, with a price target of 105.95.
What is the Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS)?
The Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS) is 6.03.
